S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Shift in war's front seen as ships cleared to leave Ukraine
What's in Democrats' big bill? Climate, health care, savings
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
What to Expect from the Markets in a Recession
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Shift in war's front seen as ships cleared to leave Ukraine
What's in Democrats' big bill? Climate, health care, savings
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
What to Expect from the Markets in a Recession
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Shift in war's front seen as ships cleared to leave Ukraine
What's in Democrats' big bill? Climate, health care, savings
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
What to Expect from the Markets in a Recession
S&P 500   4,145.19
DOW   32,803.47
QQQ   321.75
China July exports rise, with trade surplus at record-high
Shift in war's front seen as ships cleared to leave Ukraine
What's in Democrats' big bill? Climate, health care, savings
Demand for grocery delivery cools as food costs rise
Transit woes mount for Boston's beleaguered subway riders
Dems push Biden climate, health priorities toward Senate OK
What to Expect from the Markets in a Recession
NASDAQ:SPPI

Spectrum Pharmaceuticals - SPPI Stock Forecast, Price & News

$1.06
+0.12 (+13.28%)
(As of 08/5/2022 08:49 PM ET)
Add
Compare
Today's Range
$0.94
$1.12
50-Day Range
$0.70
$1.06
52-Week Range
$0.60
$2.72
Volume
4.16 million shs
Average Volume
3.23 million shs
Market Capitalization
$190.89 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$4.00

Spectrum Pharmaceuticals MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
466.0% Upside
$6.00 Price Target
Short Interest
Healthy
3.45% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.75
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Selling Shares
$12,269 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($0.51) to ($0.07) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.28 out of 5 stars

Medical Sector

353rd out of 1,283 stocks

Pharmaceutical Preparations Industry

152nd out of 615 stocks

SPPI stock logo

About Spectrum Pharmaceuticals (NASDAQ:SPPI) Stock

Spectrum Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes oncology and hematology drug products. The company's products under development include Eflapegrastim, a novel long-acting granulocyte colony-stimulating factor for chemotherapy-induced neutropenia; Poziotinib, a novel irreversible tyrosine kinase inhibitor for non-small cell lung cancer tumors with various mutations; and Anti-CD20-IFNa, an antibody-interferon fusion molecule directed against CD20 that is in Phase I development for the treatment of patients with relapsed or refractory non-Hodgkin's lymphoma, including diffuse large B-cell lymphoma. It has co-development, commercialization, and in-license agreements with Hanmi Pharmaceutical Co. Ltd.; a patent and technology license agreement with The University of Texas M.D. Anderson Cancer Center; and in-license agreement with ImmunGene, Inc. The company was formerly known as NeoTherapeutics, Inc. and changed its name to Spectrum Pharmaceuticals, Inc. in December 2002. Spectrum Pharmaceuticals, Inc. was incorporated in 1987 and is based in Henderson, Nevada.

Spectrum Pharmaceuticals Price Performance

SPPI opened at $1.06 on Monday. Spectrum Pharmaceuticals has a 52-week low of $0.60 and a 52-week high of $2.72. The stock has a market cap of $190.89 million, a P/E ratio of -1.20 and a beta of 2.01. The business has a fifty day moving average of $0.83 and a 200 day moving average of $0.86. The company has a quick ratio of 2.38, a current ratio of 2.38 and a debt-to-equity ratio of 0.10.

Spectrum Pharmaceuticals (NASDAQ:SPPI - Get Rating) last announced its earnings results on Thursday, May 12th. The biotechnology company reported ($0.09) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.18) by $0.09. As a group, sell-side analysts anticipate that Spectrum Pharmaceuticals will post -0.51 EPS for the current year.

Analysts Set New Price Targets

A number of analysts have recently weighed in on the company. Cantor Fitzgerald reissued a "neutral" rating on shares of Spectrum Pharmaceuticals in a research note on Wednesday, June 8th. StockNews.com upgraded Spectrum Pharmaceuticals from a "sell" rating to a "hold" rating in a report on Thursday, June 23rd. JMP Securities restated a "buy" rating and set a $4.00 price target on shares of Spectrum Pharmaceuticals in a report on Tuesday, June 7th. Finally, HC Wainwright reiterated a "buy" rating and issued a $10.00 price objective on shares of Spectrum Pharmaceuticals in a report on Friday, May 27th. Two research analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $6.00.

Receive SPPI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Spectrum Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SPPI Stock News Headlines

Gap to leave S&P 500 next week, moving to midcap index
See More Headlines
Receive SPPI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Spectrum Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

SPPI Company Calendar

Last Earnings
5/12/2022
Today
8/07/2022
Next Earnings (Confirmed)
8/11/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
Biotechnology
Sector
Medical
Current Symbol
NASDAQ:SPPI
CUSIP
84763A10
Employees
163
Year Founded
2002

Price Target and Rating

Average Stock Price Forecast
$6.00
High Stock Price Forecast
$10.00
Low Stock Price Forecast
$4.00
Forecasted Upside/Downside
+277.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
4 Analysts

Profitability

Net Income
$-158,630,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$0.29 per share

Miscellaneous

Free Float
175,225,000
Market Cap
$190.89 million
Optionable
Optionable
Beta
2.01

Social Links















SPPI Stock - Frequently Asked Questions

Should I buy or sell Spectrum Pharmaceuticals stock right now?

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Spectrum Pharmaceuticals in the last year. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Spectrum Pharmaceuticals stock.
View analyst ratings for Spectrum Pharmaceuticals
or view top-rated stocks.

What is Spectrum Pharmaceuticals' stock price forecast for 2022?

4 brokerages have issued 1 year price objectives for Spectrum Pharmaceuticals' stock. Their SPPI stock forecasts range from $4.00 to $10.00. On average, they expect Spectrum Pharmaceuticals' share price to reach $6.00 in the next twelve months. This suggests a possible upside of 466.0% from the stock's current price.
View analysts' price targets for Spectrum Pharmaceuticals
or view top-rated stocks among Wall Street analysts.

How has Spectrum Pharmaceuticals' stock performed in 2022?

Spectrum Pharmaceuticals' stock was trading at $1.27 at the start of the year. Since then, SPPI stock has decreased by 16.5% and is now trading at $1.06.
View the best growth stocks for 2022 here
.

When is Spectrum Pharmaceuticals' next earnings date?

Spectrum Pharmaceuticals is scheduled to release its next quarterly earnings announcement on Thursday, August 11th 2022.
View our earnings forecast for Spectrum Pharmaceuticals
.

How can I listen to Spectrum Pharmaceuticals' earnings call?

Spectrum Pharmaceuticals will be holding an earnings conference call on Thursday, August 11th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Spectrum Pharmaceuticals' earnings last quarter?

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) posted its earnings results on Thursday, May, 12th. The biotechnology company reported ($0.09) EPS for the quarter, topping the consensus estimate of ($0.18) by $0.09.

What is Joseph Turgeon's approval rating as Spectrum Pharmaceuticals' CEO?

2 employees have rated Spectrum Pharmaceuticals CEO Joseph Turgeon on Glassdoor.com. Joseph Turgeon has an approval rating of 47% among Spectrum Pharmaceuticals' employees. This puts Joseph Turgeon in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Spectrum Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Spectrum Pharmaceuticals investors own include Inovio Pharmaceuticals (INO), Verastem (VSTM), Exelixis (EXEL), SCYNEXIS (SCYX), TG Therapeutics (TGTX), Advanced Micro Devices (AMD), OPKO Health (OPK), Bausch Health Companies (BHC), Sorrento Therapeutics (SRNE) and Zynerba Pharmaceuticals (ZYNE).

What is Spectrum Pharmaceuticals' stock symbol?

Spectrum Pharmaceuticals trades on the NASDAQ under the ticker symbol "SPPI."

Who are Spectrum Pharmaceuticals' major shareholders?

Spectrum Pharmaceuticals' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Sargent Investment Group LLC (0.34%) and US Bancorp DE (0.22%). Company insiders that own Spectrum Pharmaceuticals stock include Francois Lebel, Joseph W Turgeon, Keith M Mcgahan, Kurt A Gustafson, Nora Brennan, Seth H Z Fischer, Thomas J Riga and William Ashton.
View institutional ownership trends for Spectrum Pharmaceuticals
.

How do I buy shares of Spectrum Pharmaceuticals?

Shares of SPPI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Spectrum Pharmaceuticals' stock price today?

One share of SPPI stock can currently be purchased for approximately $1.06.

How much money does Spectrum Pharmaceuticals make?

Spectrum Pharmaceuticals (NASDAQ:SPPI) has a market capitalization of $190.90 million. The biotechnology company earns $-158,630,000.00 in net income (profit) each year or ($0.88) on an earnings per share basis.

How many employees does Spectrum Pharmaceuticals have?

Spectrum Pharmaceuticals employs 163 workers across the globe.

When was Spectrum Pharmaceuticals founded?

Spectrum Pharmaceuticals was founded in 2002.

How can I contact Spectrum Pharmaceuticals?

Spectrum Pharmaceuticals' mailing address is 11500 SOUTH EASTERN AVENUE SUITE 240, HENDERSON NV, 89052. The official website for Spectrum Pharmaceuticals is www.sppirx.com. The biotechnology company can be reached via phone at (702) 835-6300, via email at ir@sppirx.com, or via fax at 702-260-7405.

This page (NASDAQ:SPPI) was last updated on 8/8/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.